SCM
ONC icon

Stevens Capital Management’s BeOne Medicines Ltd ONC Stock Holding History

Stevens Capital Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,862
Closed -$309K – 481
2019
Q4 		$309K Buy
+1,862
New +$309K 0.03% 440
2019
Q2 		– Sell
-2,642
Closed -$349K – 901
2019
Q1 		$349K Buy
+2,642
New +$356K 0.01% 550

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Stevens Capital Management's ONC Position: Q1 2020 in Review

Stevens Capital Management sold out of BeOne Medicines Ltd (ONC) in Q1 2020, closing a stake of 1,862 shares — an estimated $309K sold.

Stevens Capital Management first reported a position in ONC in Q1 2019 and held it in 2 quarters. The position peaked at $349K in Q1 2019. 215 funds tracked by Wall St. Rank hold ONC as of Q1 2020.

  • Stevens Capital Management reported no remaining BeOne Medicines Ltd position as of Q1 2020 after selling out during the quarter.
  • Stevens Capital Management sold 1,862 BeOne Medicines Ltd shares in Q1 2020, an estimated $309K.
  • Stevens Capital Management first reported a position in BeOne Medicines Ltd in Q1 2019 and held it in 2 quarters.
  • Stevens Capital Management's BeOne Medicines Ltd position peaked at $349K in Q1 2019.
  • 215 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2020.

Based on Stevens Capital Management's 13F filing for Q1 2020, filed 21 Apr 2020.